What’s New?
Due to the Covid-19 pandemic, the diagnosis of renal cell carcinoma
incidentally diagnosed is decreasing. There are serious reductions in
the number of surgeries performed for RCC. It is likely that there will
be an increase in the rates of advanced and metastatic RCC in the
following periods.